Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Aug 11;12(16):5227.
doi: 10.3390/jcm12165227.

Evaluation of Retinal Blood Flow in Patients with Monoclonal Gammopathy Using OCT Angiography

Affiliations

Evaluation of Retinal Blood Flow in Patients with Monoclonal Gammopathy Using OCT Angiography

Cecilia Czakó et al. J Clin Med. .

Abstract

Background: Monoclonal gammopathy (MG) is characterized by monoclonal protein overproduction, potentially leading to the development of hyperviscosity syndrome.

Objective: To assess retinal circulation using optical coherence tomography angiography (OCTA) parameters in patients with monoclonal gammopathy.

Methods: OCTA measurements were performed using the Optovue AngioVue system by examining 44 eyes of 27 patients with MG and 62 eyes of 36 control subjects. Superficial and deep retinal capillary vessel density (VD SVP and DVP) in the whole 3 × 3 mm macular and parafoveal area, foveal avascular zone (FAZ) area, and central retinal thickness (CRT) were measured using the AngioAnalytics software. The OCTA parameters were evaluated in both groups using a multivariate regression model, after controlling for the effect of imaging quality (SQ).

Results: There was no significant difference in age between the subjects with monoclonal gammopathy and the controls (63.59 ± 9.33 vs. 58.01 ± 11.46 years; p > 0.05). Taking into account the effect of image quality, the VD SVP was significantly lower in the MG group compared to the control group (44.54 ± 3.22% vs. 46.62 ± 2.84%; p < 0.05). No significant differences were found between the two groups regarding the other OCTA parameters (p > 0.05).

Conclusions: A decreased superficial retinal capillary vessel density measured using OCTA in patients with MG suggests a slow blood flow, reduced capillary circulation, and consequent tissue hypoperfusion. An evaluation of retinal circulation using OCTA in cases of monoclonal gammopathy may be a sensitive method for the non-invasive detection and follow-up of early microcirculatory dysfunction caused by increased viscosity.

Keywords: hyperviscosity syndrome; monoclonal gammopathy; multiple myeloma; optical coherence tomography angiography.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
En-face OCT angiogram and retinal vessel density map of the superficial retinal vascular plexus measured in the 3 × 3 mm macular using by OptoVue AngioVue OCT angiography in a patient with monoclonal gammopathy (A), and a healthy subject (B). OCT: optical coherence tomography.

Similar articles

References

    1. Kyle R.A. Monoclonal gammopathy of undetermined significance. Natural history in 241 cases. Am. J. Med. 1978;64:814–826. doi: 10.1016/0002-9343(78)90522-3. - DOI - PubMed
    1. Kyle R.A., Therneau T.M., Rajkumar S.V., Larson D.R., Plevak M.F., Offord J.R., Dispenzieri A., Katzmann J.A., Melton J.L. Prevalence of monoclonal gammopathy of undetermined significance. N. Engl. J. Med. 2006;354:1362–1369. doi: 10.1056/NEJMoa054494. - DOI - PubMed
    1. Rajkumar S.V., Dimopoulos M.A., Palumbo A., Blade J., Merlini G., Mateos M.V., Kumar S., Hillengass J., Kastritis E., Richardson P., et al. International Myeloma Working Group updated criteria for the diagnosis of multiple myeloma. Lancet Oncol. 2014;15:538–548. doi: 10.1016/S1470-2045(14)70442-5. - DOI - PubMed
    1. Kyle R.A., Larson D.R., Therneau T.M., Dispenzieri A., Kumar S., Cerhan J.R., Rajkumar S.V. Long-Term Follow-up of Monoclonal Gammopathy of Undetermined Significance. N. Engl. J. Med. 2018;378:241–249. doi: 10.1056/NEJMoa1709974. - DOI - PMC - PubMed
    1. Omoti A.E., Omoti C.E. Ophthalmic manifestations of multiple myeloma. West Afr. J. Med. 2007;26:265–268. - PubMed